Resources

Resource types
  • Resource types

  • Applications

  • Resource types

  • Applications

Learn how 6-base sequencing can reveal a more dynamic, non-invasive view of treatment response and disease progression.
Burleen Chhatwal from University College London, UK, will demonstrate how biomodal’s 6-base genome supported the successful analysis of both 5mC and 5hmC modifications in Parkinson’s disease compared to controls in a pilot study.
Robert Osborne, PhD, Senior Vice President of Research & Development provides a high-level overview of biomodal’s bioRXiv preprint, 5mC and 5hmC are synergistic biomarkers for early detection of colorectal cancer.
In part 2 of this webinar, Emily Hodges, PhD, Assistant Professor of Biochemistry at Vanderbilt University, will reveal new data that illustrates how the Hodges Lab is utilising the 6-base genome.
This Teach Me in 10 will introduce the 6‑base genome (A, T, C, G, 5mC, and 5hmC) delivered by a powerful new technology, duet multiomics solution evoC.
Join Emily Hodges, PhD, Assistant Professor of Biochemistry at Vanderbilt University, to learn more about how the Hodges Lab utilises 6-base genome to investigate the dynamics of enhancer DNA methylation during cellular differentiation.
In this Teach me in 10 episode we will explore how simultaneous sequencing of genetic and epigenetic bases in cfDNA allows for early cancer detection.
Join the Boston Epigenetics Society and biomodal founder Prof. Sir Shankar Balasubramanian FRS to discuss what DNA is trying to tell us.
Jointly brought to you by the UCLA Technical Center for Genomics & Bioinformatics (TCGB) and Jonsson Comprehensive Cancer Center (JCCC), and biomodal.

What are you looking for?